Phosphorylated Quinolone Derivatives for Anticancer Solubility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing quinolone derivatives with potent cytotoxicity are highly lipophilic, making them unsuitable for in vivo and clinical studies due to poor pharmacokinetic properties.
Innovation Solution
Development of phosphate derivatives and pharmaceutical compositions of 2-aryl-4-quinolones, 2-selenophene 4-quinolones, and 2-phenyl-4-quinolones that are water-soluble, including specific structural formulas and synthesis methods to enhance their pharmacokinetic properties for cancer treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If quinolone derivatives are designed to have potent cytotoxicity, then antitumor activity is improved, but lipophilicity increases making them unsuitable for in vivo studies
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of quinolone derivatives through phosphorylation at the 4-position carbonyl group, converting lipophilic compounds into water-soluble phosphate esters. This chemical modification changes the solubility parameter while preserving the core quinolone structure responsible for antitumor activity, thereby resolving the contradiction between cytotoxicity and pharmacokinetic suitability
Solution Approach 2:
The invention creates composite molecular structures by combining the quinolone core with phosphate groups to form hybrid molecules that exhibit both the desired biological activity of the parent compound and improved aqueous solubility. The composite structure integrates the hydrophobic quinolone moiety with the hydrophilic phosphate ester, achieving a balance between lipophilicity and water solubility
2Reliability
If quinolone derivatives are made highly lipophilic, then cytotoxicity is enhanced, but water solubility decreases making clinical studies difficult
Solution Approach 1:
The patent transforms the solubility parameter by introducing phosphate ester groups that can form hydrogen bonds with water molecules, dramatically increasing aqueous solubility. The phosphorylation modifies the molecular polarity and hydrophilicity parameters while maintaining the cytotoxic mechanism through preservation of the quinolone core structure
Solution Approach 2:
The phosphate group acts as an intermediary that bridges the hydrophobic quinolone core and the aqueous environment. This intermediate functional group provides water solubility without interfering with the core structure's ability to interact with tubulin, serving as a solubility-enhancing mediator that connects the lipophilic active moiety with the hydrophilic biological environment
3Adaptability or versatility
If phosphate derivatives are synthesized to improve water solubility, then pharmacokinetic properties are enhanced, but structural complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the molecule into distinct functional segments: the quinolone core segment responsible for biological activity and the phosphate ester segment responsible for solubility. This modular approach allows independent optimization of each segment's properties while maintaining overall molecular function, reducing the complexity burden through functional compartmentalization
Data Source
AI summary
2-aryl-4-quinolones are converted into phosphates by reacting with tetrabenzyl pyrophosphate to form dibenzyl phosphates thereof, which are then subject to hydrogenation to replace dibenzyl groups with H, followed by reacting with Amberlite IR-120(Na+ form) to form disodium salts. The results of preliminary screening revealed that these phosphates showed significant anti-cancer activity. A novel intermediate, 2-selenophene 4-quinolone and N,N-dialkylaminoalkyl derivatives of 2-phenyl-4-quinolones are also synthesized. These novel intermediates exhibited significant anticancer activities.